Keywords: Ranbaxy, Biovel, Daiichi Sankyo, M&A, Vaccines, India

India’s Ranbaxy to enter vaccines market in deal with Biovel

Article | 19 January 2010

Print This

Indian drug major Ranbaxy Laboratories, which is 64% owned by Japan’s Daiichi Sankyo, has today signed an of agreements with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in